Our past research efforts on this grant have involved the functional analysis of murine Peyer's patch (PP) lymphoreticular cells and their contribution to induction and regulation of IgA responses. Oral T-dependent (TD) antigens induce T helper (Th) cells in PP which support IgA responses and clones of these Th cells have been obtained. These PP Th cells for IgA responses (PP Th A) bear Fc receptors for IgA (FcalphaR+) and preferentially collaborate with committed, surface IgA+ B cells via FcalphaR for preferential induction of IgA responses. T-T hybridomas derived from PP Th A cells are FcalphaR+ and secrete IgA immunoglobulin-binding factor(s) (IBFalpha) which support IgA responses. We will determine: 1) the activation stage of B cells required for PP Th A cell collaboration, 2) whether lymphokines other than IBFalpha are involved in B cell triggering, and 3) the molecular basis for IBFalpha-enhancement of the IgA immune response. To accomplish this, B cells at various stages will be tested with PP Th A cells and/or derived supernatants to determine the nature of B cells which function in IgA responses. T-T cell lines will be used to obtain IBFalpha for its purification and for determining its precise role in regulation (enhancement and suppression) of IgA responses. We have isolated functional PP dendritic cells (DC), which are I-A+, 33Dl+ and which support periodate-induced mitogenic and KLH antigen-specific T cell responses. In addition, new procedures have been developed for the purification of DC. PP DC activate T cells of the Lyt-1+ phenotype and these PP DC Lyt-1+ T cell mixtures induce polyclonal IgA responses, suggesting that a unique PP DC-T cell interaction is important for IgA responses, which helps explain why PP are a major IgA inductive site. We will determine the molecular basis for DC-T cell support of polyclonal IgA responses. Periodate-induced clusters will be used to isolate T cell clones, which preferentially induce B cells to IgA synthesis, and will allow a full characterization of T cells and lymphokines required for polyclonal IgA responses. Furthermore, we will extend our studies on the functional heterogeneity of DC populations by assessing differences in: 1) induction of B cell homing and 2) antigen presentation between the two DC types. These studies will be complemented by efforts to identify unique cell surface markers and to produce tissue-specific anti-DC antibodies for use as probes in the functional studies planned.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI018958-04
Application #
3128352
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1982-09-30
Project End
1990-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
School of Medicine & Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Boyaka, Prosper N (2017) Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems. J Immunol 199:9-16
Martin, Tara L; Jee, Junbae; Kim, Eunsoo et al. (2017) Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins. Vaccine 35:2511-2519
Suzuki, Hideaki; Sekine, Shinichi; Kataoka, Kosuke et al. (2008) Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology 135:917-25
Sekine, Shinichi; Kataoka, Kosuke; Fukuyama, Yoshiko et al. (2008) A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration. J Immunol 180:8126-34
Rynda, Agnieszka; Maddaloni, Massimo; Mierzejewska, Dagmara et al. (2008) Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. J Immunol 180:5187-200
Fukuiwa, Tatsuya; Sekine, Shinichi; Kobayashi, Ryoki et al. (2008) A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity. Vaccine 26:4849-59
Kataoka, Kosuke; Fujihashi, Keiko; Sekine, Shinichi et al. (2007) Nasal cholera toxin elicits IL-5 and IL-5 receptor alpha-chain expressing B-1a B cells for innate mucosal IgA antibody responses. J Immunol 178:6058-65
Duverger, Alexandra; Jackson, Raymond J; van Ginkel, Frederick W et al. (2006) Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens. J Immunol 176:1776-83
Hagiwara, Yukari; Kawamura, Yuki I; Kataoka, Kosuke et al. (2006) A second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking. J Immunol 177:3045-54
Maddaloni, Massimo; Staats, Herman F; Mierzejewska, Dagmara et al. (2006) Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A. J Immunol 177:5524-32

Showing the most recent 10 out of 185 publications